| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,966 |
16,139 |
$1.51M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,972 |
10,378 |
$873K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,370 |
4,516 |
$323K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,427 |
4,596 |
$308K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,093 |
2,807 |
$252K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
999 |
847 |
$186K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,824 |
1,474 |
$185K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,687 |
1,460 |
$173K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,091 |
950 |
$163K |
| 01999 |
|
1,689 |
1,544 |
$130K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
926 |
791 |
$123K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,186 |
2,631 |
$122K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,402 |
1,826 |
$105K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,847 |
1,577 |
$91K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,124 |
966 |
$81K |
| 80053 |
Comprehensive metabolic panel |
13,102 |
10,469 |
$80K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,405 |
1,226 |
$79K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,634 |
2,908 |
$73K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
677 |
586 |
$55K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,794 |
4,255 |
$49K |
| 87420 |
|
891 |
858 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,082 |
2,837 |
$41K |
| 81025 |
|
1,839 |
1,565 |
$33K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
618 |
546 |
$28K |
| 71045 |
Radiologic examination, chest; single view |
5,875 |
5,041 |
$26K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,583 |
1,912 |
$25K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
843 |
718 |
$24K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,237 |
1,067 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
978 |
862 |
$22K |
| 73610 |
|
473 |
416 |
$22K |
| 81003 |
|
3,688 |
3,189 |
$20K |
| 84484 |
|
4,848 |
2,838 |
$19K |
| G0378 |
Hospital observation service, per hour |
2,554 |
1,191 |
$18K |
| 82947 |
|
2,183 |
1,114 |
$17K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,928 |
1,797 |
$14K |
| 73630 |
|
409 |
364 |
$14K |
| 81001 |
|
3,608 |
3,115 |
$13K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
90 |
81 |
$12K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
173 |
132 |
$11K |
| 73130 |
|
313 |
272 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,351 |
4,940 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,789 |
1,561 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,947 |
11,800 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
904 |
630 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,146 |
810 |
$6K |
| 96376 |
|
1,088 |
614 |
$6K |
| 87186 |
|
410 |
338 |
$4K |
| 84702 |
|
416 |
362 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
136 |
121 |
$4K |
| 86900 |
|
281 |
244 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,867 |
4,082 |
$4K |
| 80061 |
Lipid panel |
597 |
499 |
$3K |
| 73562 |
|
136 |
122 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
76 |
69 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
34 |
29 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,701 |
1,442 |
$2K |
| 84703 |
|
997 |
893 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
16 |
$1K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
101 |
39 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
294 |
228 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
70 |
64 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,987 |
1,361 |
$1K |
| 80050 |
General health panel |
58 |
53 |
$1K |
| 73030 |
|
36 |
28 |
$1K |
| 85610 |
|
1,452 |
1,206 |
$996.68 |
| 85730 |
|
1,224 |
1,028 |
$982.73 |
| 88342 |
|
193 |
165 |
$927.29 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,286 |
1,935 |
$926.48 |
| 87077 |
|
592 |
497 |
$851.99 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
116 |
100 |
$796.33 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
13 |
12 |
$707.76 |
| 83735 |
|
2,230 |
1,681 |
$645.32 |
| 83690 |
|
3,349 |
2,811 |
$642.30 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
282 |
244 |
$575.57 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
440 |
382 |
$539.94 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,284 |
2,625 |
$518.35 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
524 |
449 |
$461.71 |
| 76801 |
|
43 |
38 |
$453.48 |
| J7050 |
Infusion, normal saline solution, 250 cc |
553 |
422 |
$319.13 |
| 87040 |
|
2,395 |
1,222 |
$233.46 |
| J2704 |
Injection, propofol, 10 mg |
241 |
219 |
$228.93 |
| 83605 |
|
2,019 |
1,524 |
$223.07 |
| 73110 |
|
55 |
45 |
$218.62 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
990 |
801 |
$159.78 |
| 83880 |
|
901 |
725 |
$138.23 |
| 12002 |
|
14 |
12 |
$127.26 |
| 74022 |
|
25 |
24 |
$124.44 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
942 |
894 |
$112.20 |
| 80047 |
|
35 |
30 |
$90.42 |
| 85027 |
|
948 |
684 |
$86.82 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
322 |
188 |
$43.41 |
| 85379 |
|
201 |
171 |
$42.48 |
| 12001 |
|
12 |
12 |
$24.52 |
| 82550 |
|
87 |
66 |
$14.47 |
| 82607 |
|
42 |
38 |
$12.22 |
| 84439 |
|
30 |
25 |
$7.68 |
| 86901 |
|
282 |
244 |
$7.39 |
| 86850 |
|
133 |
116 |
$4.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
956 |
848 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
59 |
46 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
66 |
58 |
$0.00 |
| 82077 |
|
249 |
215 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
60 |
53 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
33 |
27 |
$0.00 |
| 87430 |
|
36 |
31 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
17 |
13 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18 |
12 |
$0.00 |
| 85652 |
|
17 |
16 |
$0.00 |
| 88304 |
|
13 |
12 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
179 |
148 |
$0.00 |
| 90715 |
|
22 |
13 |
$0.00 |
| 74018 |
|
39 |
38 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
15 |
14 |
$0.00 |
| 80076 |
|
14 |
13 |
$0.00 |
| 87210 |
|
55 |
44 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
115 |
99 |
$0.00 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
29 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
13 |
12 |
$0.00 |